Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(13%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
5
63%
Ph phase_2
2
25%
Ph early_phase_1
1
13%

Phase Distribution

1

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
1(12.5%)
Phase 2Efficacy & side effects
2(25.0%)
N/ANon-phased studies
5(62.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(4)
Terminated(1)
Other(2)

Detailed Status

Completed4
unknown2
Withdrawn1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (12.5%)
Phase 22 (25.0%)
N/A5 (62.5%)

Trials by Status

unknown225%
completed450%
withdrawn113%
recruiting113%

Recent Activity

1 active trials
Showing 5 of 8
completedearly_phase_1

Endocannabinoids, Stress, Craving And Pain Effects Study

NCT05480072
completednot_applicable

Mechanisms of Palmitoylethanolamide (PEA) to Alter Pain Sensitivity in Knee Osteoarthritis

NCT05406726
recruitingnot_applicable

PEA in Functional Dyspepsia

NCT05877781
unknownphase_2

PEA vs. Placebo for Major Depression

NCT06063369
withdrawnphase_2

Effect of Palmitoylethanolamide on Reducing Opioid Consumption for Below Knee Fracture Fixation

NCT05317676
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT05480072Early Phase 1

Endocannabinoids, Stress, Craving And Pain Effects Study

Completed
NCT05406726Not Applicable

Mechanisms of Palmitoylethanolamide (PEA) to Alter Pain Sensitivity in Knee Osteoarthritis

Completed
NCT05877781Not Applicable

PEA in Functional Dyspepsia

Recruiting
NCT06063369Phase 2

PEA vs. Placebo for Major Depression

Unknown
NCT05317676Phase 2

Effect of Palmitoylethanolamide on Reducing Opioid Consumption for Below Knee Fracture Fixation

Withdrawn
NCT04912921Not Applicable

Effect of Palmitoylethanolamide on Proinflammatory Markers in Adults Recently Diagnosed With COVID-19

Completed
NCT05242718Not Applicable

Immune Diversity Response to Oral Dosing of Nutritional Health Products in Healthy Participants

Completed
NCT01491191Not Applicable

Palmitoylethanolamide for Post-operative Pain Prevention

Unknown

All 8 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
8